HMGB1 and pleural mesothelioma: High expression of HMGB1 was significantly associated with poor survival (median survival time = 9.6 months), while high expression of fibulin-3 and HMGB1 combination was associated with poor survival among patients of pleural mesothelioma (median survival time = 10.5 months).